New research indicates that patients who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Published data in a leading medical journal demonstrates that while overweight individuals often shed a large proportion of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.
"People buying such medications must be cognizant of the danger of quick rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment weight in about one and a half years.
Analyzing Treatments
The analysis, which reviewed dozens of trials involving thousands of patients, compared the effects of these new drugs with other pills.
The team emphasize that people who lose weight through lifestyle changes alone usually experience a slower weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Nutrition scientists believe the mechanism of the drugs accounts for the heightened regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 levels far above than the body's typical production might result in the body to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Medical guidelines advise the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, given the significant potential of weight regain, the therapy might need to be long-term.
This opinion is supported by drug manufacturers, who say that the results "underscore the chronic character of obesity," akin to managing conditions like high blood pressure.
Patient Testimonies
People who have stopped the jabs report a intense resurgence of cravings.
"I experienced a trigger activating and you're instantly extremely hungry," described a patient.
This difficulty is compounded if users have not developed lasting lifestyle or habit modifications during treatment.
Significant Use
Recent estimates show that millions of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is more common among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, experts stress that while these medications are powerful agents for shedding pounds, they are not a standalone fix and lasting health benefits hinges on ongoing lifestyle management.
